Diagnostics Infectious Disease HTLV HTLV Blot 2.4 (FDA)

HTLV Blot 2.4 (FDA)

Name: HTLV Blot 2.4 (FDA)
SKU: 0711088036

Key features and details

HTLV Blot 2.4 is a qualitative enzyme immunoassay for the in vitro detection of antibodies to Human T- cell leukemia virus type 1 and type 2 in human serum or plasma. It is intended for use as a more specific supplemental test on human serum or plasma specimens found repeatedly reactive using screening procedures like ELISA.

SKU: 0711088036

Sample Volume:

20 uL

Packaging size:

36 Tests

Request A Custom or Bulk Quote

Product Description

HTLV Blot 2.4 is a qualitative enzyme immunoassay intended for confirming the presence of and differentiating antibodies to HTLV-I and HTLV-II in human serum and plasma. It is intended for use as a supplemental (additional, more specific) test for human serum and plasma samples with repeatedly reactive results by an FDA licensed HTLV-I/ II donor screening test. HTLV Blot 2.4 is intended for use in a manual mode or a semi-automated mode using AutoBlot System 20. This test is not intended for use in medical diagnosis.

Usage Statement

For professional use only

Specifications

SKU	0711088036
Analyte / Target	HTLV I/II antibodies
Base Catalog Number	11088036
Diagnostic Platforms	Immunoblot
Diagnostic Solutions	Infectious Disease
Disease Screened	Human T-lymphotropic virus (HTLV)
Evaluation	Qualitative
Ig Detected	IgA\|IgM\|IgG
Pack Size	36 Tests
Pathogen	Human T-cell Lymphotropic Viruses (HTLVs)
Sample Type	Human Plasma, Human Serum
Sample Volume	20 uL
Sensitivity	97.50%
Species Reactivity	Human
Usage Statement	For professional use only

Documents

Manuals

DX092019-EN-HTLV-Blot-2.4-FDA-0711088-Manual

Manuals

DX042020-EN-HTLV-2.4-FDA-0711088036-Manual-Print

Brochures

DX102019-EN-HTLV-Blot-2.4-FDA-Flyer

Citations